Internal Medicine · El Paso, TX
NPI
1316369382
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2267 Trawood Dr Ste G2
El Paso, TX, 79935
Phone (915) 221-0284
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
23,438 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Magdaleno R Cardenas Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,296 prescriptions and refills. In total Magdaleno R Cardenas Jr. wrote 23,438 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 1,296 | 1,296 | 97 | $20K |
| Levothyroxine Sodium Generic | 926 | 926 | 59 | $15K |
| Gabapentin Generic | 742 | 742 | 56 | $12K |
| Lisinopril Generic | 681 | 681 | 47 | $9,754 |
| Pantoprazole Sodium Generic | 676 | 676 | 50 | $11K |
| Metformin Hcl Generic | 663 | 663 | 52 | $9,738 |
| Amlodipine Besylate Generic | 609 | 609 | 46 | $8,667 |
| Losartan Potassium Generic | 573 | 573 | 41 | $8,705 |
| Tamsulosin Hcl Generic | 565 | 571 | 41 | $9,029 |
| Omega-3 Acid Ethyl Esters Generic | 538 | 538 | 35 | $13K |
| Carvedilol Generic | 511 | 511 | 31 | $7,698 |
| Memantine Hcl Generic | 502 | 502 | 46 | $9,635 |
| Alendronate Sodium Generic | 455 | 455 | 29 | $7,290 |
| Famotidine Generic | 438 | 438 | 33 | $6,795 |
| Omeprazole Generic | 403 | 403 | 27 | $6,058 |
Brand drugs: 2,633 claims; generic drugs: 20,675 claims; opioid claims: 374.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Magdaleno R Cardenas Jr. were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.